Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if human immunodeficiency virus
(HIV)-infected subjects with abdominal fat accumulation on their highly active antiretroviral
treatment (HAART) regimen have better changes in fat distribution after switching to
atazanavir-ritonavir than those remaining on their current protease inhibitor boosted HAART
regimen.